Keebler Health Raises $16M to Advance AI in Healthcare
Keebler Health announced a $16 million Series A round to expand its AI-driven platform for clinical and operational decision‑making. The solution uses machine learning to surface hidden risk patterns, enabling earlier interventions and cost reductions. CEO Isaac Park says the funds will accelerate product development and scale adoption across health systems. The raise reflects heightened investor appetite for AI tools that improve outcomes and efficiency.
AI‑Driven Discoveries Shift Medicine to Understanding the How
The Real Era of the Art of Medicine Begins with Artificial Intelligence. I mean, when AI discovers new treatments and runs in silico clinical trials that physicians, pharma companies, or medical innovators would never think of, our job will be understanding the...
The Front Office Is Finding Air: One Network’s Early Returns on Operational AI
Capitol Imaging, a multi‑state imaging network, partnered with AbbaDox to roll out modular operational AI, starting with a scheduling assistant and later adding fax‑processing automation. The first 90 days revealed three key realities: undocumented tribal knowledge slowed deployment, a one‑size‑fits‑all...
How AI Is Being Used in Dentistry
Artificial intelligence is rapidly reshaping UK dentistry, with roughly 40% of practices already deploying AI tools. Chat‑powered virtual receptionists now handle bookings and patient queries, cutting response times from hours to seconds and slashing missed appointments. Clinical AI analyzes X‑rays...
INBRAIN Neuroelectronics Completes Patient Recruitment for First-in-Human Study Evaluating Its Graphene Cortical Interface
INBRAIN Neuroelectronics announced that patient recruitment is complete for its first‑in‑human trial of a graphene‑based cortical interface. Ten patients were enrolled, and eight underwent surgery without any peri‑operative device failures, yielding complete datasets. The study, run with the University of...
11 Key Features to Look for in Medical Practice Management Software for Healthcare Providers
Administrative tasks still consume 15%‑25% of U.S. healthcare spending—about $1 trillion annually—largely due to manual processes. The article outlines 11 essential features of modern medical practice management software that can replace paper charts, spreadsheets, and fax‑based billing with integrated digital workflows....
An ‘AI Scientist’ Can Tackle Drug R&D. What Does that Mean for Pharma?
AI agents are moving from analytical tools to autonomous coworkers in pharma, with Owkin’s K Pro platform acting as an “AI scientist” that can answer complex research questions in hours rather than weeks. The system pulls together literature, gene‑expression data, and...
Tees, Esk and Wear Talking Therapies Improvement Challenge Highlights Steps to Improve Uptake of Digital
Tees, Esk and Wear Valleys NHS Foundation Trust completed a 100‑day improvement challenge aimed at boosting confidence among adults 65+ in using digital talking‑therapies. Over 240 seniors participated, with 96% reporting regular use of phones, tablets or laptops. Video‑based therapy...
AI Tools Let Surgeons Evaluate Heart Transplants in Minutes, Cutting Wait Times
At the ISHLT 46th Annual Meeting, Dr. Brian Wayda unveiled AI models that let surgeons gauge donor‑heart suitability in minutes. The tools, including the TOPHAT web predictor, could raise the current 30‑40% utilization rate of available hearts and ease the...
Most Pixel Owners Are Ignoring One of the Phone’s Strangest Built-In Sensors
Google’s Pixel 10 Pro houses an infrared temperature sensor that earned FDA De Novo clearance in 2024, allowing the phone to take body temperature readings with ±0.3 °C accuracy. The built‑in Thermometer app lets users log temperatures for fevers, food safety, and home‑efficiency checks....
Robotic Phlebotomy Study Signals Automation Shift for Clinical Labs
Vitestro’s autonomous robotic phlebotomy system Aletta completed a multicenter ADOPT trial involving 1,633 patients, achieving a 94.5% first‑stick success rate and markedly low hemolysis (0.3%) and adverse events (0.6%). Patient surveys showed 90% experienced equal or less pain, with 82%...
The Fifteen-Year-Old Who Just Earned a PhD and Is Specialising in Immortality
Laurent Simons, a Belgian prodigy, defended a quantum‑physics PhD at just 15, becoming one of the youngest doctorate holders in history. Within weeks he relocated to Munich to begin a second doctorate that fuses medical science with artificial intelligence, aiming...
Rapid Blood Infection Test Fails to Improve Survival
A large, open‑label randomized trial of 899 patients with gram‑negative bacteremia compared rapid antimicrobial susceptibility testing directly from positive blood cultures to standard sub‑culture testing. The rapid approach delivered susceptibility results in about 7.5 hours versus 44 hours for the conventional method,...
EU Unlocks €63M to Accelerate AI in Health and Safety
The European Commission has announced €63.2 million (about $68 million) in new funding under the Digital Europe Programme to accelerate AI innovation in healthcare, digital skills and online safety. Approximately €9 million will support AI‑driven image screening in medical centres, while €24 million targets...
New Nanomedicine Approach Boosts Chemotherapy And Immune Activity In Pancreatic Cancer
A preclinical mouse study published in Advanced Science demonstrates that photoactivatable multi‑inhibitor liposomes (PMILs) can deliver irinotecan directly to pancreatic ductal adenocarcinoma (PDAC) tumors when activated by light. The regimen combines minocycline‑mediated DNA‑repair inhibition, photodynamic priming, and localized chemotherapy, boosting...
New Study Published Evaluating PharmaSens All-in-One Insulin Patch Pump
PharmaSens AG announced that the Journal of Diabetes Science and Technology published data from the first clinical feasibility study of its niia all‑in‑one insulin patch pump, which combines insulin delivery with continuous glucose monitoring. The single‑arm trial enrolled 18 adults...
BioAegis and Prenosis Partner for Inflammatory Disease Therapies
BioAegis Therapeutics has teamed up with AI‑focused startup Prenosis to accelerate precision‑medicine approaches for inflammatory diseases. The partnership will analyze biospecimens from BioAegis’s Phase II BTI‑203 trial of recombinant human plasma gelsolin in 600 ARDS patients across Europe, Canada and the...
New Tool Launches to Support Women Through Post-Loss Journey
Carea has introduced a free "Healing After Loss" mode within its pregnancy and postnatal wellbeing app, offering on‑demand mental‑health tools, expert guidance, and a peer community for women who have experienced miscarriage or baby loss. The feature activates automatically when...
Emulsion Gel for Intestine‐Specific Enzyme‐Triggered Release of Probiotics
Researchers have created a water‑in‑oil jammed Pickering emulsion gel (JPEG) that encapsulates probiotics, protecting them from the acidic environment of the stomach and releasing them only in the intestine. The probiotics‑loaded JPEG (PL‑JPEG) exhibits shear‑thinning behavior, high stability against pH,...
On‐Chip Evaluation of Red Blood Cell Deformability Through Transit Velocity Index in Hematological Diseases
Researchers have introduced a microfluidic platform that measures red blood cell (RBC) deformability using a transit velocity index (V^ε=0.5) derived from capillary‑like constrictions. The index reliably tracks stiffness changes when RBCs are chemically stiffened with diamide, confirming its sensitivity. Applying...
Artera’s Prostate Biopsy and Breast Cancer Assays Receive CE Mark
Artera announced that its ArteraAI prostate biopsy and breast cancer assays have received CE marking under the EU In Vitro Diagnostic Regulation, expanding the company’s reach to the European market. The prostate assay is the first AI‑enabled prognostic and predictive test...
AI Chatbots Recommending Chemo Alternatives, Study Warns
A study by the Lundquist Institute evaluated major AI chatbots—including Grok, ChatGPT, Gemini, Meta AI and DeepSeek—on cancer‑treatment queries. Experts rated almost half of the responses as problematic, with 30% deemed somewhat inaccurate and 19.6% highly misleading. The bots often...
Calibre Emerges From Stealth with $3.3M to Tackle “Health Guesswork” Through Causal AI
Calibre, a London‑based healthtech startup, emerged from stealth with a $3.3 million pre‑seed round led by Amino Collective. The company introduces “Causal Health Navigation,” a clinician‑guided causal AI platform that identifies the true drivers of an individual’s health. Priced at £69...
The Definitive Infrastructure for Modern Drug Development
Paradigm Health has launched an AI‑powered clinical research platform that operates across a national network of more than 800 community and academic sites in the United States, Japan and Israel. The platform embeds trial design, patient identification and data capture...
Register for HTN Now Webinars, Covering AVT in Trusts, Digital Patient Pathways, AI in Primary Care, 10 Year Plan From...
HTN is launching a series of free, online webinars for NHS professionals that run from late April through May. Each session deep‑dives into a specific digital‑health topic, from ambient‑scribe AI and paperless NHS initiatives to AI in primary care and...
National Commission Into the Regulation of AI in Healthcare Offers Early Insights From Call for Evidence
The UK National Commission into the Regulation of AI in Healthcare released early findings from a call for evidence that attracted more than 770 responses, underscoring strong public demand for regulatory reform. Deputy chair Henrietta Hughes emphasized trust, post‑market surveillance,...
New "Plug-and-Play" AI Outperforms Pathologists in Lymph Node Metastasis Detection
HKUST researchers unveiled PRET, a plug‑and‑play AI pathology system that learns new cancer types from just one to eight annotated slides. The model achieved AUC scores above 97% on 15 of 20 benchmark tasks, including a perfect 100% for colorectal...
Lentinan‐Enhanced Mn3O4 Nanoparticles for Neuroinflammation Relief and Parkinson's Disease Treatment
Researchers have engineered a lentinan‑coated manganese oxide (Mn3O4@LNT) nanoparticle that can circulate long‑term and cross the blood‑brain barrier (BBB). Proteomic analysis revealed that the LNT coating reshapes the particle’s protein corona, enhancing BBB traversal and brain accumulation. In cellular and...
The World’s First RealTime AI Assistant for Pancreatic EUS, Available for Clinical Use in the UK.
Fannin UK has launched mAI Companion®, a real‑time AI assistant for pancreatic endoscopic ultrasound (EUS) that received MDR CE Mark approval, making it the first AI‑driven EUS tool cleared for clinical use in the UK. Developed with IHU‑Strasbourg and trained...
The Next Phase of Diabetes Care
Diabetes technology is advancing rapidly, with smarter algorithms, longer‑wear sensors, and smaller pumps reshaping care. Automated insulin delivery systems now pair continuous glucose monitors with ultra‑rapid, ultra‑concentrated insulin, offering tighter glucose control. Adoption remains limited—only about 40% of type 1 and...
Oscar Health Turns Health Insurance Into Consumer Marketplace
Airbnb for healthcare?? Oscar Health has an interesting history. They were the first health insurance company to give clients a health tracker. If they proved through data that they lived an active life, they received benefits and rewards. As healthcare is the...
Interpretable Machine Learning of Non-Traditional Lipid Indices for Diagnostic Classification of CHD in Patients with Comorbid MASLD and T2DM: A...
Patients with metabolic dysfunction‑associated steatotic liver disease (MASLD) and type 2 diabetes face a markedly higher risk of coronary heart disease, yet standard lipid panels often miss residual risk. A multicenter retrospective analysis of 1,823 such patients identified eight non‑traditional...
Digital Health Exclusion Mapped
The Digital Exclusion Risk Atlas (DERA) has been launched as an online tool to pinpoint areas in England where residents face barriers to digital health services, such as poor connectivity, affordability constraints, or limited digital skills. By combining device access,...
New Algorithms Help Surgeons Make High-Stakes Transplant Decisions in Minutes
Researchers at the ISHLT meeting unveiled AI tools designed to speed heart‑transplant decisions, aiming to cut the 15‑30 minute evaluation window. The flagship model, TOPHAT, analyzes 20 donor variables to predict a center’s likelihood of accepting a heart, while a...
From Brain Implant to Lifelong Companion: Michel Maharbiz Unveils Epia Neuro
Epia Neuro, a stealth‑mode neurotechnology startup co‑founded by Michel Maharbiz, announced its public debut at the Bioelectronic Medicine Forum. The company, now 45‑strong and backed by venture and pharma investors, is developing a skull‑mounted, dura‑sparing neural interface designed for outpatient...
From Governance to Enablement: How Healthcare CIOs Can Stop Killing AI Innovation
Healthcare CIOs risk stifling AI projects by treating governance as a barrier. Tony Pastorino argues that rebranding oversight as data enablement and forming cross‑functional teams can unlock responsible innovation. He advises separating idea generation from compliance checks and focusing on...
CNN Hunts Real Patient Stories on ChatGPT Health Use
It must be a milestone if CNN is actively looking for patient stories of using ChatGPT for health issues. Using generative AI is not newsworthy enough to be covered frequently. Also, there are many patient stories out there proving that...
Tele‑Operated Micro‑Robot Delivers Ultra‑Precise Minimally Invasive Surgery
Tele-Operated Micro-#Robot Enables Ultra-Precise Minimally Invasive Surgery by @VicariousSurg #HealthTech #Tech #Technology #EmergingTech #TechForGood https://t.co/bVGDoHbWui
Urine Biomarker May Predict Bladder Cancer Treatment Response, Study Finds
Stanford researchers have created a urine‑based liquid biopsy that detects tumor DNA to predict which non‑muscle invasive bladder cancer (NMIBC) patients will benefit from BCG immunotherapy. In a Cell‑published study, patients with detectable tumor DNA after BCG had a high...
Wireless EMG Bionic Hand Achieves Independent Finger Control
Wireless EMG-Controlled Bionic Hand with Independent Finger Movement by @CyberRobooo #Robotics #Engineering #ArtificialIntelligence #Innovation #Technology https://t.co/gaGcSxExhU
WGS Uncovers KMT2A PTD, Surpassing Old AML Tests
Detection of KMT2A partial tandem duplication (PTD) in AML by whole genome sequencing (WGS): Addressing limitations of traditional techniques in the era of revumenib approval - Huether et al. #ASCO25 Abst 6532 https://t.co/EEsXm7JGdv #AMLsm #leusm #PrecisionMedicine @TempusAI
NIH‑Backed AI Model Beats Baselines in Rare Lung Disease Detection
A National Institutes of Health‑funded team unveiled the WEakly Supervised Transformer (WEST) algorithm, which outperformed all baseline models in identifying two rare lung diseases from electronic health records. The breakthrough could shorten diagnostic delays for patients with pulmonary hypertension and...
First Tumor NGS Usage Varies Across Top Five Cancers
Utilization and timing of first tumor next-generation sequencing testing (NGS) in Pts w/ 5 most common cancers in the USA - @chadihcmd et al. @huntsmancancer #ASCO25 Abstract 11014 https://t.co/lWefncnTb2 #PrecisionMedicine #hemonc #bcsm #crcsm #lcsm #pancsm #pcsm https://t.co/oIX8QTRD8x
NIH-Funded AI Model Predicts Cancer Survival From Single-Cell Tumor Data
Researchers at Oregon Health & Science University, funded by the NIH, unveiled scSurvival, an AI model that predicts cancer patient survival from single‑cell tumor data. The tool was evaluated on clinical datasets from more than 150 melanoma and liver cancer...
Nanox Posts $33.4M Q4 Loss, Announces 360‑System Distribution Deal
Nanox (NASDAQ:NNOX) disclosed a $33.4 million net loss for Q4 2025 and $3.7 million in revenue, while CEO Erez Meltzer highlighted a new distribution agreement covering roughly 360 Nanox.ARC systems over the next two to three years. The update also noted a CFO...
Lakeridge and Partners Go Live on Sectra Cloud
Lakeridge Health and six regional partners have launched Sectra One Cloud, a cloud‑based diagnostic imaging platform that unifies access to X‑rays, CT scans and MRIs across 13 sites in Ontario’s Central East Region. The system handles roughly one million imaging...
Tava Health Secures $40 Million Series C to Scale AI‑Powered Behavioral Health Platform
Tava Health announced a $40 million Series C round led by Centana Growth Partners, bringing its total funding to $73 million since 2020. The capital will fund three new AI‑enabled products—Overture, Symphony, and Tempo—and deepen support for clinicians, clinics, and health plans....
Drummondville Docs Express Doubts About Quebec EHR
Fourteen of the sixteen internists in Drummondville have warned that Quebec's Digital Health Record (DHR) rollout could jeopardize patient safety and disrupt clinical workflows. They petitioned the CIUSSS of Mauricie‑and‑Centre‑du‑Québec to delay the May 9 launch, citing inadequate equipment and training....
AGE-WELL Creates AI & Aging Council
AGE-WELL has launched an AI & Aging Council to steer the responsible development and governance of artificial intelligence for Canada’s aging population. The council brings together leaders from industry, academia, care organizations, older adults and caregivers to advise on AI...
VHA Launches AI-Driven Client Portal
VHA Home HealthCare has added the Evha AI Assistant to its myVHA client portal, offering real‑time navigation and service information. The tool answers questions about portal use, VHA programs, and caregiver support while adhering to strict AI governance. VHA’s leadership...